Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels
<i>Background</i>: The role of statins in prostate cancer (PCa) remains unclear. Conflicting evidence has been found concerning risk reduction with the use of statins on biochemical recurrence (BCR). In this study, we evaluated whether statin use decreases the incidence of advanced PCa i...
Main Authors: | Dennie Meijer, R. Jeroen A. van Moorselaar, André N. Vis, Irene V. Bijnsdorp |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/7/953 |
Similar Items
-
Impact of Statin Use on Localized Prostate Cancer Outcomes after Radiation Therapy: Long-Term Follow-Up
by: Kevin Kaulanjan, et al.
Published: (2022-07-01) -
Outcomes of Salvage Prostate Cryotherapy: Real-life Experience of a Portuguese Oncologic Hospital
by: Luísa Jerónimo Alves, et al.
Published: (2021-09-01) -
Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer
by: Shinichi Takeuchi, et al.
Published: (2023-02-01) -
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
by: Takuya Aizawa, et al.
Published: (2023-10-01) -
Ureteric obstruction secondary to unusual metastasis of prostate cancer
by: Alexandar Blazevski, et al.
Published: (2020-07-01)